These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 208584)

  • 1. Regulation of cholesterol synthesis in the hyperlipoproteinaemias. Polymorphonuclear leucocyte abnormality specific to familial type II hypercholesterolaemia.
    Bremner WF; Third JL; Clark B; Corstorphine C; Lawrie TD
    Atherosclerosis; 1978 Mar; 29(3):291-9. PubMed ID: 208584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity in type II hyperlipoproteinaemia.
    Betteridge DJ; Higgins MJ; Galton DJ
    Br Med J; 1975 Nov; 4(5995):500-2. PubMed ID: 172188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia.
    Sigurdsson G; Nicoll A; Lewis B
    Eur J Clin Invest; 1976 Mar; 6(2):151-8. PubMed ID: 177294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
    Bagnall TF; Lloyrd JK
    Clin Chim Acta; 1975 Mar; 59(3):271-6. PubMed ID: 165017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells.
    Mistry P; Miller NE; Laker M; Hazzard WR; Lewis B
    J Clin Invest; 1981 Feb; 67(2):493-502. PubMed ID: 6257763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses.
    Gianturco SH; Packard CJ; Shepherd J; Smith LC; Catapano AL; Sybers HD; Gotto AM
    Lipids; 1980 Jun; 15(6):456-63. PubMed ID: 7401943
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and the esterification of cholesterol in human long term lymphoid cell lines.
    Kayden HJ; Hatam L; Beratis NG
    Biochemistry; 1976 Feb; 15(3):521-8. PubMed ID: 1252410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia.
    Mabuchi H; Tatami R; Ueda K; Ueda R; Haba T; Kametani T; Watanabe A; Wakasugi T; Ito S; Koizumi J; Ohta M; Miyamoto S; Takeda R
    Atherosclerosis; 1979 Apr; 32(4):435-44. PubMed ID: 223596
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma lipoproteins: recent developments.
    Gotto AM; Jackson RL
    Adv Exp Med Biol; 1977; 82():15-33. PubMed ID: 200086
    [No Abstract]   [Full Text] [Related]  

  • 13. The biochemical composition and metabolism of lipoproteins in type V hyperlipoproteinaemia.
    Simons LA; Williams PF
    Clin Chim Acta; 1975 Jun; 61(3):341-52. PubMed ID: 168008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating lipoproteins and regulation of cholesterol metabolism].
    Ailhaud G
    Biochimie; 1977; 59(8-9):XI-XIV. PubMed ID: 202337
    [No Abstract]   [Full Text] [Related]  

  • 15. A new type of familial hypercholesterolaemia.
    Higgins MJ; Lecamwasam DS; Galton DJ
    Lancet; 1975 Oct; 2(7938):737-40. PubMed ID: 52771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cholesterol synthesis and binding of lipoproteins in cultured rat intestinal epithelial cells.
    Nano JL; Barbaras R; Négrel R; Rampal P
    Biochim Biophys Acta; 1986 Mar; 876(1):72-9. PubMed ID: 3633199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.
    Ballantyne D; Olsson AG; Carlson LA
    Atherosclerosis; 1978 May; 30(1):79-87. PubMed ID: 209798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diet therapy in hyperlipoproteinemias].
    Canzler H
    Z Allgemeinmed; 1974 Jan; 50(2):53-61. PubMed ID: 4361378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.